Cephalexin tablets are a distinct oral product format with U.S. DailyMed labels describing 250 mg and 500 mg strengths. A tablet record can identify approved product characteristics without proving that the item is currently marketed in every channel or stocked locally. This distinction matters when patients search for cephalexin tablets and see historical product listings alongside ordinary capsule offers.
For a prescription specifying tablets, verify the precise strength, manufacturer, NDC when relevant, and dispensing authorization. A tablet is not simply a capsule with a different picture. The capsule-versus-tablet comparison explains practical differences, while the form index shows where liquid fits.
The purpose of this page is product identification and pharmacy confirmation, not creating a tablet buying promise. Ask a licensed pharmacy whether it can fill the exact prescription and what the prescriber must clarify if only capsules appear in its catalog. See supply verification for the current-stock workflow.
DailyMed provides tablet-specific information including active ingredient, 250 mg and 500 mg strengths and example packaging characteristics. Some labels describe a tablet’s shape, imprint or score mark. Those details identify a particular manufacturer product and may not describe other products, especially if listings have changed over time.
The table outlines practical decisions to resolve before buying. For broader category information, see all oral forms and 250 mg or 500 mg strength pages.
A displayed tablet photograph may correspond to one specific product and NDC, such as a tablet described by a particular imprint on a label. Do not apply that identification to every cephalexin tablet or infer that a later marketing status is unchanged. Regulatory source records and the pharmacist’s current dispensing system answer different questions; both matter when a patient requests a less common form.
| Question | Why it matters | Next step |
|---|---|---|
| Is the order for tablets? | Dosage form is an authorized prescription field | Confirm with the prescriber or pharmacist |
| Is the strength 250 mg or 500 mg? | Each strength is a different product unit | Check the actual package label |
| Does a product listing reflect current supply? | Labels can remain searchable without local inventory | Verify availability |
| Does the tablet show a score? | Scoring alone does not establish a patient-specific split dose | Ask pharmacist about the exact product |
| Can a capsule replace the tablet? | Form changes are not self-directed | Compare forms |
| Would generic substitution apply? | FDA equivalence and state rules are product-specific | Substitution guide |
A tablet label may provide color, shape and imprint details for the identified manufacturer’s 250 mg or 500 mg product. This is useful for pharmacy verification but should not be generalized to every cephalexin tablet. Tablets with the same active ingredient can differ in inactive ingredients and appearance.
A score line may have pharmaceutical relevance, yet whether a patient should split the tablet is a separate clinical and dispensing question. Do not split, crush or use a partial tablet dose based only on the physical appearance of a product.
Even a scored tablet should not be assumed appropriate for a half-tablet regimen. The reason for the score, suitability of dividing the particular product, and exact directions are details that pharmacy staff should confirm. A tablet breaking unevenly or being crushed without instruction can create inconsistent administration; asking about an authorized alternate form is safer than improvising.
An FDA approval record and a DailyMed label are sources of product information, not evidence that a store can obtain a pack today. Products can have changed marketing status, been replaced by other presentations or become difficult to locate through local wholesalers. Even a currently marketed product can be out of stock in one pharmacy.
Use the availability guide for questions to ask a pharmacist. If a specific NDC is important, ask for verification of both the NDC’s product identity and the ability to dispense it, rather than drawing stock conclusions from a search engine result.
Both product formats can contain oral cephalexin, but the dispensed formulation must be appropriate for the prescription and patient. Different physical forms may create swallowing, manufacturer and substitution questions. A matching number of milligrams is necessary for a strength comparison but is not the only criterion for an authorized substitution.
For a side-by-side review, use tablet and capsule differences. The pharmacy may need to consult the prescriber when a particular form cannot be supplied.
Swallowing difficulties, feeding needs or sensitivity to particular excipients can make dosage form important. Ask whether the exact prescribed tablet must be swallowed intact, and whether an alternate prescribed form would be more practical. Avoid online suggestions to chew, crush or dissolve an antibiotic tablet without verifying instructions for that product.
If liquid could be more suitable, review liquid versus solid administration and oral suspension products. The clinician must authorize a new formulation and clear measuring directions as needed.
The manufacturer and package may affect the label appearance, inactive ingredients and NDC. FDA generic standards address approved products, but the individual pharmacist must determine the dispensed item and whether a proposed change is permitted. The discontinued status of a historic brand does not by itself settle whether generic tablets exist.
FDA Orange Book searches and manufacturer information can support product research. Neither resource replaces a pharmacist’s assessment of the actual order, product availability or permitted substitution.
A 250 mg or 500 mg label refers to strength per tablet, not a universal adult or pediatric treatment regimen. Infection type, susceptibility, kidney function and other patient factors influence appropriate prescribing. Selecting tablet strengths based on price or pill size is not a substitute for prescriber instructions.
See the dosing overview and renal considerations for medication safety context. Anyone with a suspected serious allergic reaction should seek immediate evaluation rather than attempting to adjust the product.
Ask whether the pharmacy has the exact tablet product, which manufacturer and strength it would dispense, whether it can fill the written tablet prescription, and what the pickup or delivery conditions are. If the answer is uncertain, request prescriber communication rather than ordering an unverified replacement.
The online pharmacy safety guide explains licensure checks, and local pharmacy pickup addresses in-person verification. Never assume an online catalogue reflects a confirmed shelf quantity.
If an online seller says tablets are in stock, the patient should still verify state pharmacy licensure, access to a licensed pharmacist and how the seller processes the original prescription. The checkout page cannot establish an authorized therapeutic-equivalence decision or guarantee the product will actually be dispensed. When the prescribed tablet is unobtainable, the next step is prescriber/pharmacist coordination.
A tablet’s storage requirements are found on its own label. Product records for cephalexin tablets describe room-temperature storage and protection consistent with the labeled package. Keep the dispensing label attached and ask the pharmacist about damage, moisture exposure or a product whose appearance is unexpected.
Do not take a loose unidentified tablet or one from an unverified seller. A plausible imprint is not sufficient evidence of origin or quality, and a pharmacist can assist with proper identification or disposal.
Tablet product prices are influenced by the exact strength, package and pharmacy or payer arrangements, if the product is obtainable. A cash price advertised for capsules does not automatically apply to a tablet prescription. Do not use cheaper unit pricing as a reason to change an antibiotic regimen.
Review evergreen price factors and cash-pay comparison steps after the pharmacist confirms that the product can actually be dispensed.
U.S. labels document 250 mg and 500 mg cephalexin tablets, but the current ability to dispense a given tablet should be checked directly with a licensed pharmacy. Verify form, strength and manufacturer information against the written prescription, and do not substitute capsules or split tablets by assumption.
Affiliate links may generate referral compensation for this site. That does not guarantee tablet inventory, establish medical suitability or constitute an endorsement of any seller.
U.S. DailyMed product labeling includes cephalexin tablets. Availability of a particular tablet and pharmacy supply must be confirmed separately.
Cephalexin tablet labels describe 250 mg and 500 mg strengths. The exact product and marketing status may vary.
Do not split a tablet based solely on the score line. Ask the dispensing pharmacist whether that specific tablet may be split and whether doing so matches the prescription.
Not automatically. Pharmacists must assess the specific product, prescription and applicable substitution rules.
A searchable product label does not mean the item is stocked through every pharmacy or wholesaler. The pharmacy can check its dispensing options.
No. An NDC identifies a listed product and package; it does not establish retail availability today.
No. Cephalexin tablets are prescription antibiotics in the United States.
Not necessarily. Unit strength and administration schedule are separate prescription fields determined by the prescriber.